Clinical management of bispecific antibody therapy for lymphoma: a British Society for Haematology good practice paper
Chaganti, Sridhar Dulobdas, Vaishali Wilson, Matthew R Tucker, David Townsend, William Parry-Jones, Nilima Lewis, David Fox, Christopher P Osborne, Wendy
Chaganti, Sridhar
Dulobdas, Vaishali
Wilson, Matthew R
Tucker, David
Townsend, William
Parry-Jones, Nilima
Lewis, David
Fox, Christopher P
Osborne, Wendy
Abstract
No abstract available
MIDER Authors
Affiliations
University Hospitals Birmingham NHS Foundation Trust; Beatson West of Scotland Cancer Centre; Royal Cornwall Hospitals NHS Trust; University College London Hospitals NHS Foundation Trust; Aneurin Bevan University Health Board; University Hospitals Plymouth NHS Trust; University of Nottingham; Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University
Date
2025-09-05
Type
Article
Collections
Citation
Chaganti S, Dulobdas V, Wilson MR, Tucker D, Townsend W, Parry-Jones N, Lewis D, Fox CP, Osborne W. Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper. Br J Haematol. 2025 Oct;207(4):1227-1241. doi: 10.1111/bjh.70018. Epub 2025 Sep 5.